Madhya Bharat Agro Products Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 8, 2025, 5:07 pm

Quick Insight

Madhya Bharat Agro Products Ltd, operating in the fertilisers sector, presents a compelling yet complex investment case with its current share price at ₹430 and a market capitalization of ₹3,765 crore. The company exhibits a high price-to-earnings (P/E) ratio of 50.8, indicating that investors are paying a premium for its earnings, which may reflect growth expectations. With a return on equity (ROE) of 15.2% and return on capital employed (ROCE) of 18%, the firm demonstrates efficient use of capital, despite a modest operating profit margin (OPM) of 12%. However, a concerning cash conversion cycle (CCC) of 178 days and significant borrowings of ₹318 crore against reserves of ₹316 crore suggest liquidity challenges. The promoter holding at 74.51% indicates strong insider confidence, yet the absence of foreign institutional investors (FIIs) could deter broader market interest. Ultimately, while the fundamentals show potential,

Competitors of Madhya Bharat Agro Products Ltd

All Competitor Stocks of Madhya Bharat Agro Products Ltd

Quarterly Result

Last Updated: August 1, 2025, 5:45 pm

Below is a detailed analysis of the quarterly data for Madhya Bharat Agro Products Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 410.00 Cr.. The value appears strong and on an upward trend. It has increased from 297.00 Cr. (Mar 2025) to 410.00 Cr., marking an increase of 113.00 Cr..
• For Expenses, as of Jun 2025, the value is 353.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 261.00 Cr. (Mar 2025) to 353.00 Cr., marking an increase of 92.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 57.00 Cr.. The value appears strong and on an upward trend. It has increased from 36.00 Cr. (Mar 2025) to 57.00 Cr., marking an increase of 21.00 Cr..
• For OPM %, as of Jun 2025, the value is 14.00%. The value appears strong and on an upward trend. It has increased from 12.00% (Mar 2025) to 14.00%, marking an increase of 2.00%.
• For Other Income, as of Jun 2025, the value is 3.00 Cr.. The value appears to be declining and may need further review. It has decreased from 6.00 Cr. (Mar 2025) to 3.00 Cr., marking a decrease of 3.00 Cr..
• For Interest, as of Jun 2025, the value is 7.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 7.00 Cr..
• For Depreciation, as of Jun 2025, the value is 9.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 8.00 Cr. (Mar 2025) to 9.00 Cr., marking an increase of 1.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 44.00 Cr.. The value appears strong and on an upward trend. It has increased from 27.00 Cr. (Mar 2025) to 44.00 Cr., marking an increase of 17.00 Cr..
• For Tax %, as of Jun 2025, the value is 36.00%. The value appears to be improving (decreasing) as expected. It has decreased from 47.00% (Mar 2025) to 36.00%, marking a decrease of 11.00%.
• For Net Profit, as of Jun 2025, the value is 28.00 Cr.. The value appears strong and on an upward trend. It has increased from 14.00 Cr. (Mar 2025) to 28.00 Cr., marking an increase of 14.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 3.22. The value appears strong and on an upward trend. It has increased from 1.63 (Mar 2025) to 3.22, marking an increase of 1.59.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: July 22, 2025, 3:26 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: May 13, 2025, 3:10 pm

Below is a detailed analysis of the balance sheet data for Madhya Bharat Agro Products Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 88.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 88.00 Cr..
• For Reserves, as of Mar 2025, the value is 316.00 Cr.. The value appears strong and on an upward trend. It has increased from 263.00 Cr. (Mar 2024) to 316.00 Cr., marking an increase of 53.00 Cr..
• For Borrowings, as of Mar 2025, the value is 318.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 290.00 Cr. (Mar 2024) to 318.00 Cr., marking an increase of 28.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 223.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 163.00 Cr. (Mar 2024) to 223.00 Cr., marking an increase of 60.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 946.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 804.00 Cr. (Mar 2024) to 946.00 Cr., marking an increase of 142.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 279.00 Cr.. The value appears strong and on an upward trend. It has increased from 265.00 Cr. (Mar 2024) to 279.00 Cr., marking an increase of 14.00 Cr..
• For CWIP, as of Mar 2025, the value is 74.00 Cr.. The value appears strong and on an upward trend. It has increased from 14.00 Cr. (Mar 2024) to 74.00 Cr., marking an increase of 60.00 Cr..
• For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Other Assets, as of Mar 2025, the value is 592.00 Cr.. The value appears strong and on an upward trend. It has increased from 525.00 Cr. (Mar 2024) to 592.00 Cr., marking an increase of 67.00 Cr..
• For Total Assets, as of Mar 2025, the value is 946.00 Cr.. The value appears strong and on an upward trend. It has increased from 804.00 Cr. (Mar 2024) to 946.00 Cr., marking an increase of 142.00 Cr..

However, the Borrowings (318.00 Cr.) are higher than the Reserves (316.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Madhya Bharat Agro Products Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 24, the value is 2.84. This value is below the healthy minimum of 5. It has decreased from 28.35 (Mar 23) to 2.84, marking a decrease of 25.51.
• For Diluted EPS (Rs.), as of Mar 24, the value is 2.84. This value is below the healthy minimum of 5. It has decreased from 28.35 (Mar 23) to 2.84, marking a decrease of 25.51.
• For Cash EPS (Rs.), as of Mar 24, the value is 6.15. This value is within the healthy range. It has decreased from 33.45 (Mar 23) to 6.15, marking a decrease of 27.30.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 40.05. It has decreased from 74.95 (Mar 23) to 40.05, marking a decrease of 34.90.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 40.05. It has decreased from 74.95 (Mar 23) to 40.05, marking a decrease of 34.90.
• For Dividend / Share (Rs.), as of Mar 24, the value is 0.50. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 23) which recorded 0.50.
• For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 93.23. It has decreased from 224.14 (Mar 23) to 93.23, marking a decrease of 130.91.
• For PBDIT / Share (Rs.), as of Mar 24, the value is 12.27. This value is within the healthy range. It has decreased from 49.07 (Mar 23) to 12.27, marking a decrease of 36.80.
• For PBIT / Share (Rs.), as of Mar 24, the value is 8.96. This value is within the healthy range. It has decreased from 43.96 (Mar 23) to 8.96, marking a decrease of 35.00.
• For PBT / Share (Rs.), as of Mar 24, the value is 5.96. This value is within the healthy range. It has decreased from 40.21 (Mar 23) to 5.96, marking a decrease of 34.25.
• For Net Profit / Share (Rs.), as of Mar 24, the value is 2.84. This value is within the healthy range. It has decreased from 28.35 (Mar 23) to 2.84, marking a decrease of 25.51.
• For PBDIT Margin (%), as of Mar 24, the value is 13.16. This value is within the healthy range. It has decreased from 21.89 (Mar 23) to 13.16, marking a decrease of 8.73.
• For PBIT Margin (%), as of Mar 24, the value is 9.61. This value is below the healthy minimum of 10. It has decreased from 19.61 (Mar 23) to 9.61, marking a decrease of 10.00.
• For PBT Margin (%), as of Mar 24, the value is 6.39. This value is below the healthy minimum of 10. It has decreased from 17.93 (Mar 23) to 6.39, marking a decrease of 11.54.
• For Net Profit Margin (%), as of Mar 24, the value is 3.04. This value is below the healthy minimum of 5. It has decreased from 12.64 (Mar 23) to 3.04, marking a decrease of 9.60.
• For Return on Networth / Equity (%), as of Mar 24, the value is 7.07. This value is below the healthy minimum of 15. It has decreased from 37.82 (Mar 23) to 7.07, marking a decrease of 30.75.
• For Return on Capital Employeed (%), as of Mar 24, the value is 17.32. This value is within the healthy range. It has decreased from 45.31 (Mar 23) to 17.32, marking a decrease of 27.99.
• For Return On Assets (%), as of Mar 24, the value is 3.08. This value is below the healthy minimum of 5. It has decreased from 16.71 (Mar 23) to 3.08, marking a decrease of 13.63.
• For Long Term Debt / Equity (X), as of Mar 24, the value is 0.08. This value is below the healthy minimum of 0.2. It has decreased from 0.12 (Mar 23) to 0.08, marking a decrease of 0.04.
• For Total Debt / Equity (X), as of Mar 24, the value is 0.82. This value is within the healthy range. It has decreased from 0.98 (Mar 23) to 0.82, marking a decrease of 0.16.
• For Asset Turnover Ratio (%), as of Mar 24, the value is 1.06. It has decreased from 1.66 (Mar 23) to 1.06, marking a decrease of 0.60.
• For Current Ratio (X), as of Mar 24, the value is 1.38. This value is below the healthy minimum of 1.5. It has decreased from 1.58 (Mar 23) to 1.38, marking a decrease of 0.20.
• For Quick Ratio (X), as of Mar 24, the value is 0.78. This value is below the healthy minimum of 1. It has decreased from 0.90 (Mar 23) to 0.78, marking a decrease of 0.12.
• For Inventory Turnover Ratio (X), as of Mar 24, the value is 2.66. This value is below the healthy minimum of 4. It has decreased from 3.51 (Mar 23) to 2.66, marking a decrease of 0.85.
• For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 8.81. This value is below the healthy minimum of 20. It has increased from 0.88 (Mar 23) to 8.81, marking an increase of 7.93.
• For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 4.06. This value is below the healthy minimum of 20. It has increased from 0.74 (Mar 23) to 4.06, marking an increase of 3.32.
• For Earning Retention Ratio (%), as of Mar 24, the value is 91.19. This value exceeds the healthy maximum of 70. It has decreased from 99.12 (Mar 23) to 91.19, marking a decrease of 7.93.
• For Cash Earning Retention Ratio (%), as of Mar 24, the value is 95.94. This value exceeds the healthy maximum of 70. It has decreased from 99.26 (Mar 23) to 95.94, marking a decrease of 3.32.
• For Interest Coverage Ratio (X), as of Mar 24, the value is 4.10. This value is within the healthy range. It has decreased from 13.08 (Mar 23) to 4.10, marking a decrease of 8.98.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 1.95. This value is below the healthy minimum of 3. It has decreased from 8.56 (Mar 23) to 1.95, marking a decrease of 6.61.
• For Enterprise Value (Cr.), as of Mar 24, the value is 2,391.74. It has decreased from 2,791.41 (Mar 23) to 2,391.74, marking a decrease of 399.67.
• For EV / Net Operating Revenue (X), as of Mar 24, the value is 2.93. This value is within the healthy range. It has increased from 2.84 (Mar 23) to 2.93, marking an increase of 0.09.
• For EV / EBITDA (X), as of Mar 24, the value is 22.24. This value exceeds the healthy maximum of 15. It has increased from 12.98 (Mar 23) to 22.24, marking an increase of 9.26.
• For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 2.59. This value is within the healthy range. It has increased from 2.54 (Mar 23) to 2.59, marking an increase of 0.05.
• For Retention Ratios (%), as of Mar 24, the value is 91.18. This value exceeds the healthy maximum of 70. It has decreased from 99.11 (Mar 23) to 91.18, marking a decrease of 7.93.
• For Price / BV (X), as of Mar 24, the value is 6.02. This value exceeds the healthy maximum of 3. It has decreased from 7.58 (Mar 23) to 6.02, marking a decrease of 1.56.
• For Price / Net Operating Revenue (X), as of Mar 24, the value is 2.59. This value is within the healthy range. It has increased from 2.54 (Mar 23) to 2.59, marking an increase of 0.05.
• For EarningsYield, as of Mar 24, the value is 0.01. This value is below the healthy minimum of 5. It has decreased from 0.04 (Mar 23) to 0.01, marking a decrease of 0.03.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness